Shareholders of Walgreens Boots Alliance, Inc. Should Contact The Gross Law Firm Before March 31, 2025 to Discuss Your Rights - WBA

1. WBA shareholders may be eligible for lead plaintiff in a class action lawsuit. 2. The lawsuit claims WBA misled investors regarding regulatory compliance issues. 3. Allegations include ongoing violations of federal laws on prescription medication. 4. Unlawful conduct purportedly made WBA's revenues unsustainable and misleading. 5. Deadline to register for the class action is March 31, 2025.

Legal

75

4m saved

Insight

Article

FAQ

Why Bearish?

Legal issues and lawsuits often negatively affect stock valuations and investor sentiment. Similar cases have driven stocks lower due to reputational damage and potential liabilities.

How important is it?

The article addresses a significant lawsuit that could adversely impact WBA's stock. Legal disputes related to compliance issues often draw intense scrutiny from both investors and regulators.

Why Short Term?

The effects of announcements like this typically unfold quickly as investors react. Historical examples show sharp declines in stock price after lawsuit announcements.

Related Companies

WBA

NEW YORK, Feb. 13, 2025 /PRNewswire/ --

The Gross Law Firm issues the following notice to shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA).

Shareholders who purchased shares of WBA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/walgreens-boots-alliance-inc-loss-submission-form-2/?id=128954&from=4

CLASS PERIOD:

April 2, 2020 to January 16, 2025

ALLEGATIONS:

The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

DEADLINE:

March 31, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/walgreens-boots-alliance-inc-loss-submission-form-2/?id=128954&from=4

NEXT STEPS FOR SHAREHOLDERS:

Once you register as a shareholder who purchased shares of WBA during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is March 31, 2025. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM?

The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: info@grosslawfirm.com
Phone: (646) 453-8903

SOURCE The Gross Law Firm